•
ZL
ZLAB
Zai Lab Limited American Depositary Shares
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
2.09B
Volume
723.38K
52W High
$44.34
52W Low
$16.82
Open
$0.00
Prev Close
$18.91
Day Range
0.00 - 0.00
About Zai Lab Limited American Depositary Shares
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Latest News
Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback
Benzinga•Sep 11
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities
Benzinga•Jul 16
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
GlobeNewswire Inc.•Jul 7
argenx and Zai Lab Announce Approval of Efgartigimod Alfa - GlobeNewswire
GlobeNewswire Inc.•Jul 16
Top 5 Health Care Stocks That Are Preparing To Pump In February
Benzinga•Feb 9
Archer-Daniels-Midland, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Benzinga•Jan 22
What Makes Zai Lab Limited Unsponsored ADR (ZLAB) a New Buy Stock
Zacks Investment Research•Dec 22
Paychex Reports Downbeat Sales, Joins BlackBerry And Other Big Stocks Moving Lower On Thursday
Benzinga•Dec 21